11β-Hydroxysteroid Dehydrogenase Type 1 Gene Knockout Attenuates Atherosclerosis and In Vivo Foam Cell Formation in Hyperlipidemic apoE^−/− Mice

• Ricardo A. García,

  Affiliation Cardiovascular Drug Discovery, Bristol-Myers Squibb Company, Pennington, New Jersey, United States of America

  ⨯
• Debra J. Search,

  Affiliation Cardiovascular Drug Discovery, Bristol-Myers Squibb Company, Pennington, New Jersey, United States of America

  ⨯
• John A. Lupisella,

  Affiliation Cardiovascular Drug Discovery, Bristol-Myers Squibb Company, Pennington, New Jersey, United States of America

  ⨯
• Jacek Ostrowski,

  Affiliation Cardiovascular Drug Discovery, Bristol-Myers Squibb Company, Pennington, New Jersey, United States of America

  ⨯
• Bo Guan,

  Affiliation Applied Genomics, Bristol-Myers Squibb Company, Pennington, New Jersey, United States of America

  ⨯
• Jian Chen,

  Affiliation Applied Genomics, Bristol-Myers Squibb Company, Pennington, New Jersey, United States of America

  ⨯
• Wen-Pin Yang,

  Affiliation Applied Genomics, Bristol-Myers Squibb Company, Pennington, New Jersey, United States of America

  ⨯
• Amy Truong,

  Affiliation Applied Genomics, Bristol-Myers Squibb Company, Pennington, New Jersey, United States of America

  ⨯
• Aiqing He,

  Affiliation Applied Genomics, Bristol-Myers Squibb Company, Pennington, New Jersey, United States of America

  ⨯
• Rongan Zhang,

  Affiliation Cardiovascular Drug Discovery, Bristol-Myers Squibb Company, Pennington, New Jersey, United States of America

  ⨯
• Mujing Yan,

  Affiliation Cardiovascular Drug Discovery, Bristol-Myers Squibb Company, Pennington, New Jersey, United States of America

  ⨯
• Samuel E. Hellings,

  Affiliation Cardiovascular Drug Discovery, Bristol-Myers Squibb Company, Pennington, New Jersey, United States of America

  ⨯
• Peter S. Gargalovic,

  Affiliation Cardiovascular Drug Discovery, Bristol-Myers Squibb Company, Pennington, New Jersey, United States of America

  ⨯
• Carol S. Ryan,

  Affiliation Cardiovascular Drug Discovery, Bristol-Myers Squibb Company, Pennington, New Jersey, United States of America

  ⨯
• Linda M. Watson,

  Affiliation Pharmaceutical Compound Optimization: Discovery Toxicology, Bristol-Myers Squibb Company, Lawrenceville, New Jersey, United States of America

  ⨯
• Robert A. Langish,

  Affiliation Pharmaceutical Compound Optimization: Discovery Analytical Sciences, Bristol-Myers Squibb Company, Pennington, New Jersey, United States of America

  ⨯
• Petia A. Shipkova,

  Affiliation Pharmaceutical Compound Optimization: Discovery Analytical Sciences, Bristol-Myers Squibb Company, Pennington, New Jersey, United States of America

  ⨯
• Nancy L. Carson,

  Affiliation Cardiovascular Drug Discovery, Bristol-Myers Squibb Company, Pennington, New Jersey, United States of America

  ⨯
• Joseph R. Taylor,

  Affiliation Metabolic Diseases, Bristol-Myers Squibb Company, Pennington, New Jersey, United States of America

  ⨯
• Richard Yang,

  Affiliation Cardiovascular Drug Discovery, Bristol-Myers Squibb Company, Pennington, New Jersey, United States of America

  ⨯
• George C. Psaltis,

  Affiliation Veterinary Sciences, Bristol-Myers Squibb Company, Pennington, New Jersey, United States of America

  ⨯
• Thomas W. Harrity,

  Affiliation Cardiovascular Drug Discovery, Bristol-Myers Squibb Company, Pennington, New Jersey, United States of America

  ⨯
• Jeffrey A. Robl,

  Affiliation Discovery Chemistry, Bristol-Myers Squibb Company, Pennington, New Jersey, United States of America

  ⨯
•  [ ... ],
• David A. Gordon

  * E-mail: david.gordon@bms.com

  Affiliation Cardiovascular Drug Discovery, Bristol-Myers Squibb Company, Pennington, New Jersey, United States of America

  ⨯
• [ view all ]
• [ view less ]